Literature DB >> 19299458

Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.

Ryohei Umezawa1, Masanobu Yamada, Kazuhiko Horiguchi, Sumiyasu Ishii, Koshi Hashimoto, Shuichi Okada, Teturou Satoh, Masatomo Mori.   

Abstract

We reported a novel mutation of thyroid hormone receptor (TR)-beta, F455S, in a patient with pituitary resistance to thyroid hormone (RTH), who showed impaired release of nuclear receptor corepressor and abnormal histone deacetylation. In the present study, we further analyzed the histone modifications and the dynamics of TR and RNA polymerase II on the TRH gene. The lysine residues 9 (H3K9) and 14 (K14) of the histone H3 were acetylated in the absence of thyroid hormone (TH), and addition of TH caused a temporary deacetylation of both residues. Although H3K4 was di- and trimethylated in the absence of T(3), no methylation of H3K9 or K27 was detected. Long-term incubation with T(3) decreased the level of trimethylated H3K4, the amount of TR, and the level of phosphorylated RNA polymerase II but not dimethylated H3K4. Treatment with an inhibitor for H3K4 methyltransferase, 5'-deoxy-5'-methylthioadenosine, decreased basal promoter activity but did not affect the repression by TH. Conversely, overexpression of MLL, an H3K4-specific methyltransferase, caused an increase in basal activity. In the presence of F455S, methylation of H3K4 and the dynamics of TR were intact, but both H3K9 and H3K14 were hyperacetylated, and T(3)-induced deacetylation was impaired, resulting in a high transcriptional level. These findings demonstrated that 1) negative regulation of the TRH gene by TH involves both the acetylation and methylation of specific residues of histone tails and changing the amount of TR, and 2) the major impairment to histone modifications in F455S was hyperacetylation of the specific histone tails.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299458      PMCID: PMC2703523          DOI: 10.1210/en.2008-1738

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.

Authors:  T Satoh; T Monden; T Ishizuka; T Mitsuhashi; M Yamada; M Mori
Journal:  Mol Cell Endocrinol       Date:  1999-08-20       Impact factor: 4.102

Review 2.  Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation.

Authors:  Michael Hampsey; Danny Reinberg
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

Review 3.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

4.  Deciphering the transcriptional histone acetylation code for a human gene.

Authors:  Theodora Agalioti; Guoying Chen; Dimitris Thanos
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

5.  Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo.

Authors:  Dipali Sharma; Joseph D Fondell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus.

Authors:  T P Segerson; J Kauer; H C Wolfe; H Mobtaker; P Wu; I M Jackson; R M Lechan
Journal:  Science       Date:  1987-10-02       Impact factor: 47.728

7.  Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.

Authors:  T Tagami; L D Madison; T Nagaya; J L Jameson
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

Authors:  Yujiang Shi; Fei Lan; Caitlin Matson; Peter Mulligan; Johnathan R Whetstine; Philip A Cole; Robert A Casero; Yang Shi
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

9.  Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.

Authors:  S Ishii; M Yamada; T Satoh; T Monden; K Hashimoto; N Shibusawa; K Onigata; A Morikawa; M Mori
Journal:  Mol Endocrinol       Date:  2004-05-06

10.  The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements.

Authors:  A N Hollenberg; T Monden; T R Flynn; M E Boers; O Cohen; F E Wondisford
Journal:  Mol Endocrinol       Date:  1995-05
View more
  11 in total

1.  Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8- and deiodinase-2-deficient mice.

Authors:  Beatriz Morte; Ainhoa Ceballos; Diego Diez; Carmen Grijota-Martínez; Alexandra M Dumitrescu; Caterina Di Cosmo; Valerie Anne Galton; Samuel Refetoff; Juan Bernal
Journal:  Endocrinology       Date:  2010-03-08       Impact factor: 4.736

2.  Impaired Repressor Function in SUMOylation-Defective Thyroid Hormone Receptor Isoforms.

Authors:  Joachim M Weitzel
Journal:  Eur Thyroid J       Date:  2016-08-04

3.  Desensitization and Incomplete Recovery of Hepatic Target Genes After Chronic Thyroid Hormone Treatment and Withdrawal in Male Adult Mice.

Authors:  Kenji Ohba; Melvin Khee-Shing Leow; Brijesh Kumar Singh; Rohit Anthony Sinha; Ronny Lesmana; Xiao-Hui Liao; Sujoy Ghosh; Samuel Refetoff; Judy Chia Ghee Sng; Paul Michael Yen
Journal:  Endocrinology       Date:  2016-02-11       Impact factor: 4.736

4.  Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in mice.

Authors:  Nancy M Benight; Barbara Stoll; Juan C Marini; Douglas G Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-03       Impact factor: 4.052

5.  Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.

Authors:  Kumar Pandya; Benjamin Pulli; Scott Bultman; Oliver Smithies
Journal:  Gene Expr       Date:  2010

6.  METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis.

Authors:  Xueju Wei; Yue Huo; Jingnan Pi; Yufeng Gao; Shuan Rao; Manman He; Qinglv Wei; Peng Song; Yiying Chen; Dongxu Lu; Wei Song; Junbo Liang; Lingjie Xu; Haixia Wang; Guolin Hong; Yuehong Guo; Yanmin Si; Jiayue Xu; Xiaoshuang Wang; Yanni Ma; Shuyang Yu; Dongling Zou; Jing Jin; Fang Wang; Jia Yu
Journal:  Nat Cell Biol       Date:  2022-08-04       Impact factor: 28.213

7.  Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo.

Authors:  Arunoday Bhan; Imran Hussain; Khairul I Ansari; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-14       Impact factor: 4.292

8.  Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10.

Authors:  Theresa Porst; Jörg Johannes; Hans Gluschke; Richard Köhler; Sebastian Mehl; Peter Kühnen; Kostja Renko; Waldemar B Minich; Susanna Wiegand; Lutz Schomburg
Journal:  Biomedicines       Date:  2021-04-30

9.  Multiple novel signals mediate thyroid hormone receptor nuclear import and export.

Authors:  Manohara S Mavinakere; Jeremy M Powers; Kelly S Subramanian; Vincent R Roggero; Lizabeth A Allison
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

10.  NR4A1 (Nur77) mediates thyrotropin-releasing hormone-induced stimulation of transcription of the thyrotropin β gene: analysis of TRH knockout mice.

Authors:  Yasuyo Nakajima; Masanobu Yamada; Ryo Taguchi; Nobuyuki Shibusawa; Atsushi Ozawa; Takuya Tomaru; Koshi Hashimoto; Tsugumichi Saito; Takafumi Tsuchiya; Shuichi Okada; Tetsurou Satoh; Masatomo Mori
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.